AGM/EGMApr 27, 2026, 04:34 PM
ABEO Annual Meeting June 12; Equity Plan Increase, Director Nominees
AI Summary
Abeona Therapeutics Inc. announced its Annual Meeting of Stockholders will be held virtually on June 12, 2026. Stockholders will vote on the election of three Class 1 directors, an advisory resolution on executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor. Key proposals also include increasing shares reserved for the 2023 Equity Incentive Plan from 8.4 million to 11.5 million and amending the Certificate of Incorporation to remove the advance notice provision for director nominations.
Key Highlights
- Abeona Therapeutics Inc. will hold its Annual Meeting of Stockholders virtually on June 12, 2026, at 9:00 a.m. ET.
- Proposes to elect Michael Amoroso, Keith A. Goldan, and Bernhardt G. Zeiher, M.D. as Class 1 directors.
- Seeks advisory approval for the compensation of the Company's named executive officers.
- Proposes to ratify Deloitte & Touche LLP as independent auditor for the fiscal year ending December 31, 2026.
- Requests approval to increase shares for the 2023 Equity Incentive Plan from 8,400,000 to 11,500,000.
- Proposes to amend the Certificate of Incorporation to remove the advance notice provision for director nominations.
- The record date for voting is April 15, 2026, with 56,882,523 shares of Common Stock outstanding.
Price Impact
More from ABEO